1-4 of 4
Kentaro Bandobashi
Close
Sort by
Journal Articles

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama
Journal: Blood
Blood (2007) 110 (6): 2034–2040.
https://doi.org/10.1182/blood-2007-02-073700
Published: 2007
Journal Articles

The Anti-Tumor Effects of SU11248, a Class III Receptor Tyrosine Kinase Inhibitor, Against a Variety of Human Hematological Malignancies.

Takayuki Ikezoe, MD, Kentaro Bandobashi, MD, Yang Yang, Tsuyako Saito, MD, Kazuto Togitani, MD, Taizo Tasaka, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD
Journal: Blood
Blood (2005) 106 (11): 2795.
https://doi.org/10.1182/blood.V106.11.2795.2795
Published: 2005
Journal Articles

HIV-1 Protease Inhibitor Ritonavir Potentiates the Effect of 1,25-Dihydroxyvitamin D 3 to Induce Growth Arrest and Differentiation of Human Myeloid Leukemia Cells Via Inhibition of CYP24.

Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi, Nobuo Sekiguchi, Shuichi Sakai, H. Phillip Koeffler, Hirokuni Taguchi
Journal: Blood
Blood (2004) 104 (11): 2543.
https://doi.org/10.1182/blood.V104.11.2543.2543
Published: 2004
Journal Articles

Human Herpesvirus 6 (HHV-6)–Positive Burkitt's Lymphoma: Establishment of a Novel Cell Line Infected With HHV-6

Kentaro Bandobashi, Masanori Daibata, Mikio Kamioka, Yuji Tanaka, Ichiro Kubonishi, Hirokuni Taguchi, Yuji Ohtsuki, Isao Miyoshi
Journal: Blood
Blood (1997) 90 (3): 1200–1207.
https://doi.org/10.1182/blood.V90.3.1200
Published: 1997